Midterm Outcome of Cementless Total Hip Arthroplasty in Crowe IV-Hartofilakidis Type III Developmental Dysplasia of the Hip

详细信息    查看全文

• 作者：Wenbo Mu ; MD¹ ; Desheng Yang ; MD¹ ; Boyong Xu ; MD ; Askar Mamtimin ; MD ; Wentao Guo ; MD ; Li Cao ; MD
• 关键词：total hip arthroplasty ; crowe IV&ndash ; hartofilakidis type III developmental dysplasia of the hip ; intraoperative fracture ; midterm outcome
• 刊名：The Journal of Arthroplasty
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：31
• 期：3
• 页码：668-675
• 全文大小：806 K

文摘

Developmental dysplasia of the hip (DDH) is widespread in developing countries, and treating Crowe IV–Hartofilakidis Type III DDH in adults requires the use of a highly demanding technique.

Methods

We sought to determine the outcome of cementless total hip arthroplasty using Zweymüller components to treat Crowe IV–Hartofilakidis Type III DDH. Fifty-eight patients (71 hips) with a mean age of 35.8 years at time of index operation were included in our study. The average duration of follow-up was 70.5 months. The acetabular component was placed in the true acetabulum in all cases, and subtrochanteric shortening osteotomy was performed in 61 hips.

Results

With any component revision for any reason as the end point, Kaplan–Meier survivorship analysis at 98 months revealed a cumulative survival rate for implanted components of 91.40%. The mean Harris Hip Score improved from 35.6 preoperatively to 82.9 postoperatively. There were 20 cases of intraoperative fracture, 1 case of complete nerve palsy, and 7 cases of transient nerve palsy. Revision surgery was performed in 7 patients because of cup loosening in 1, severe polyethylene wear in 4, cup breakage in 1, and dislocation in 1.

Conclusions

Midterm results for cementless total hip arthroplasty in patients with Crowe IV–Hartofilakidis Type III DDH was satisfactory; however, intraoperative fracture and polyethylene wear were major complications.